120 related articles for article (PubMed ID: 8846997)
1. Protective effects of glucose-6-phosphate and NADP against alpha-chaconine-induced developmental toxicity in Xenopus embryos.
Rayburn JR; Bantle JA; Qualls CW; Friedman M
Food Chem Toxicol; 1995 Dec; 33(12):1021-5. PubMed ID: 8846997
[TBL] [Abstract][Full Text] [Related]
2. Synergistic interaction of glycoalkaloids alpha-chaconine and alpha-solanine on developmental toxicity in Xenopus embryos.
Rayburn JR; Friedman M; Bantle JA
Food Chem Toxicol; 1995 Dec; 33(12):1013-9. PubMed ID: 8846996
[TBL] [Abstract][Full Text] [Related]
3. Developmental toxicology of potato alkaloids in the frog embryo teratogenesis assay--Xenopus (FETAX).
Friedman M; Rayburn JR; Bantle JA
Food Chem Toxicol; 1991 Aug; 29(8):537-47. PubMed ID: 1894220
[TBL] [Abstract][Full Text] [Related]
4. Amelioration by glucose-6-phosphate and NADP of potato glycoalkaloid inhibition in cell, enzyme and liposome assays.
Roddick JG; Leonard AL
Phytochemistry; 1999 May; 51(1):23-7. PubMed ID: 10349728
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the developmental toxicity of thalidomide using frog embryo teratogenesis assay-xenopus (FETAX): biotransformation and detoxification.
Fort DJ; Stover EL; Bantle JA; Finch RA
Teratog Carcinog Mutagen; 2000; 20(1):35-47. PubMed ID: 10607376
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the developmental toxicity of caffeine and caffeine metabolites using the frog embryo teratogenesis assay--Xenopus (FETAX).
Fort DJ; Stover EL; Propst TL; Faulkner BC; Vollmuth TA; Murray FJ
Food Chem Toxicol; 1998 Jul; 36(7):591-600. PubMed ID: 9687966
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the mechanism of isoniazid-induced developmental toxicity with frog embryo teratogenesis assay: Xenopus (FETAX).
Fort DJ; Bantle JA
Teratog Carcinog Mutagen; 1990; 10(6):463-76. PubMed ID: 1982910
[TBL] [Abstract][Full Text] [Related]
8. Phase III interlaboratory study of FETAX. Part 3. FETAX validation using 12 compounds with and without an exogenous metabolic activation system.
Bantle JA; Finch RA; Fort DJ; Stover EL; Hull M; Kumsher-King M; Gaudet-Hull AM
J Appl Toxicol; 1999; 19(6):447-72. PubMed ID: 10547627
[TBL] [Abstract][Full Text] [Related]
9. The folic acid analogue methotrexate protects frog embryo cell membranes against damage by the potato glycoalkaloid alpha-chaconine.
McWilliams ML; Blankemeyer JT; Friedman M
Food Chem Toxicol; 2000 Oct; 38(10):853-9. PubMed ID: 11039318
[TBL] [Abstract][Full Text] [Related]
10. Development of a metabolic activation system for the frog embryo teratogenesis assay: Xenopus (FETAX).
Fort DJ; Dawson DA; Bantle JA
Teratog Carcinog Mutagen; 1988; 8(5):251-63. PubMed ID: 2905834
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the developmental toxicity of five compounds with the frog embryo teratogenesis assay: Xenopus (FETAX) and a metabolic activation system.
Fort DJ; James BL; Bantle JA
J Appl Toxicol; 1989 Dec; 9(6):377-88. PubMed ID: 2613998
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the developmental toxicities of ethanol, acetaldehyde, and thioacetamide using FETAX.
Fort DJ; McLaughlin DW; Rogers RL; Buzzard BO
Drug Chem Toxicol; 2003 Feb; 26(1):23-34. PubMed ID: 12643038
[TBL] [Abstract][Full Text] [Related]
13. Optimization of an exogenous metabolic activation system for FETAX. I. Post-isolation rat liver microsome mixtures.
Fort DJ; Rogers RL; Stover EL; Finch RA
Drug Chem Toxicol; 2001 May; 24(2):103-15. PubMed ID: 11360429
[TBL] [Abstract][Full Text] [Related]
14. Phase III interlaboratory study of FETAX, Part 2: interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay--Xenopus (FETAX).
Fort DJ; Stover EL; Bantle JA; Rayburn JR; Hull MA; Finch RA; Burton DT; Turley SD; Dawson DA; Linder G; Buchwalter D; Dumont JN; Kumsher-King M; Gaudet-Hull AM
Drug Chem Toxicol; 1998 Feb; 21(1):1-14. PubMed ID: 9530526
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the developmental toxicity of 4-bromobenzene using frog embryo teratogenesis assay--Xenopus: possible mechanisms of action.
Fort DJ; Propst TL; Stover EL
Teratog Carcinog Mutagen; 1996; 16(6):307-15. PubMed ID: 9178453
[TBL] [Abstract][Full Text] [Related]
16. Assessing the predictive validity of frog embryo teratogenesis assay-Xenopus (FETAX).
Fort DJ; Stover EL; Farmer DR; Lemen JK
Teratog Carcinog Mutagen; 2000; 20(2):87-98. PubMed ID: 10679752
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Xenopus tropicalis as an alternative test organism for frog embryo teratogenesis assay--Xenopus (FETAX).
Song MO; Fort DJ; McLaughlin DL; Rogers RL; Thomas JH; Buzzard BO; Noll AM; Myers NK
Drug Chem Toxicol; 2003 Aug; 26(3):177-89. PubMed ID: 12953658
[TBL] [Abstract][Full Text] [Related]
18. The use of in vitro fertilization in the Frog Embryo Teratogenesis Assay in Xenopus (FETAX) and its applications to ecotoxicology.
Vismara C; Bernardini G; Bonfanti P; Colombo A; Camatini M
Sci Total Environ; 1993; Suppl Pt 1():787-90. PubMed ID: 8108713
[TBL] [Abstract][Full Text] [Related]
19. Optimization of an exogenous metabolic activation system for FETAX. II. Preliminary evaluation.
Fort DJ; Rogers RL; Paul RR; Stover EL; Finch RA
Drug Chem Toxicol; 2001 May; 24(2):117-27. PubMed ID: 11360430
[TBL] [Abstract][Full Text] [Related]
20. Studies of an S9-based metabolic activation system used in the mouse lymphoma L5178Y cell mutation assay.
McGregor DB; Edwards I; Riach CG; Cattanach P; Martin R; Mitchell A; Caspary WJ
Mutagenesis; 1988 Nov; 3(6):485-90. PubMed ID: 3070287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
